Physician

Kulsum Bano, MD

According to 2025 Medicare claims, Kulsum Bano, MD (NPI: 1114378775) practices hematology/oncology in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from York, SC. This provider's primary affiliated billing organization is THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY (NPI: 1306269691; TIN: 56-0529945) and primary practice location at 29732-0281. Bano is affiliated with the Carolinas HealthCare System ACO, LLC (ACO ID: A3675), participating under the MSSP model.

Bano's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 449 traditional Medicare patients, billed 132,032 HCPCS/CPT codes, and received $2,235,136 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 685 prescription claims across 149 beneficiaries totaling $615,225 in drug costs, led by Jakafi (Ruxolitinib Phosphate). 2020 DME data shows 96 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $8,637 to $615,225. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.1M$2.2M2019 Medicare payment: $23,923 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $31,853 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $267,049 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,235,136 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019110286$23,923
2020140365$31,853
2021N/RN/RN/R
2022N/RN/RN/R
202314617,102$267,049
2024449132,032$2,235,136

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$308K$615K2017 Drug cost: $8,637 (USD; Tot_Drug_Cst)2018 Drug cost: $8,651 (USD; Tot_Drug_Cst)2019 Drug cost: $8,994 (USD; Tot_Drug_Cst)2020 Drug cost: $14,012 (USD; Tot_Drug_Cst)2021 Drug cost: $33,427 (USD; Tot_Drug_Cst)2022 Drug cost: $292,699 (USD; Tot_Drug_Cst)2023 Drug cost: $231,235 (USD; Tot_Drug_Cst)2024 Drug cost: $615,225 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
201728231$8,637
201820161$8,651
201954152$8,994
202082215$14,012
202144135$33,427
202248170$292,699
202351111$231,235
2024149685$615,225

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$2.7K$5.4K2020 Medicare payment: $5,438 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R96$5,438
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less114318$91
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more187345$90
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more82108$65
80053Blood test, comprehensive group of blood chemicals247617$10
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count269720$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JakafiRuxolitinib Phosphate13390$223,909
EliquisApixaban402,460$26,924
AnastrozoleAnastrozole1138,848$2,589
LetrozoleLetrozole523,340$831
DexamethasoneDexamethasone13345$326

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Kulsum Bano, MD?

Tedicare shows public-source Medicare data for Kulsum Bano, MD (NPI 1114378775), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kulsum Bano, MD have ACO affiliation data?

Kulsum Bano, MD is shown with ACO affiliation data for Carolinas HealthCare System ACO, LLC (MSSP, ACO ID A3675).

What billing organization is linked to Kulsum Bano, MD?

Kulsum Bano, MD is linked to THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY (billing NPI 1306269691) in the available physician profile data.

Does Kulsum Bano, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.